DANAHER CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 250.4 USD | -1.07% |
|
+4.19% | +8.24% |
| Apr. 24 | HSBC Adjusts Danaher's Price Target to $290 From $280 | MT |
| Apr. 24 | TD Cowen Adjusts Price Target on Danaher to $290 From $280 | MT |
Financials (USD)
| Sales 2024 * | 23.9B | Sales 2025 * | 26.01B | Capitalization | 187B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.44B | Net income 2025 * | 5.38B | EV / Sales 2024 * | 8.2 x |
| Net Debt 2024 * | 8.58B | Net Debt 2025 * | 1.24B | EV / Sales 2025 * | 7.26 x |
| P/E ratio 2024 * |
42.1
x | P/E ratio 2025 * |
34.4
x | Employees | 62,000 |
| Yield 2024 * |
0.44% | Yield 2025 * |
0.47% | Free-Float | 74.94% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danaher Corporation
More recommendations
More press releases
More news
| 1 day | -1.07% | ||
| 1 week | +4.19% | ||
| Current month | +0.28% | ||
| 1 month | -1.72% | ||
| 3 months | +7.89% | ||
| 6 months | +22.72% | ||
| Current year | +8.24% |
1 week
230.74
256.72
1 month
230.74256.72
Current year
222.53259.00
1 year
182.09269.61
3 years
182.09333.96
5 years
119.60333.96
10 years
70.12333.96
| Managers | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 60 | 09-12-31 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
Alan Spoon
BRD | Director/Board Member | 72 | 99-06-30 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.99% | 18 M€ | +4.24% | - | |
| 3.77% | 2 M€ | +2.32% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 250.4 | -1.07% | 3,064,441 |
| 24-04-23 | 253.1 | +7.21% | 6,876,672 |
| 24-04-22 | 236.1 | +0.24% | 2,820,270 |
| 24-04-19 | 235.5 | -0.36% | 2,351,430 |
| 24-04-18 | 236.4 | -1.27% | 4,261,041 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotes
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
2024-07-17
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
253.1
USD
Average target price
269.2
USD
Spread / Average Target
+6.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.24% | 187B | |
| +8.78% | 219B | |
| +11.16% | 134B | |
| +26.12% | 101B | |
| +0.30% | 62.27B | |
| +16.21% | 52.82B | |
| -1.63% | 47.49B | |
| -1.11% | 40.79B | |
| +12.16% | 39.35B | |
| +6.84% | 27.06B |
- Stock Market
- Equities
- DHR Stock
